Unilever Reports Q4 Revenue Growth Amid Strategic Cost Discipline

Unilever PLC delivered a 3.2% rise in quarterly revenue, reaching £5.9 billion for the period ending December 2025, according to its latest financial update. The growth was primarily fueled by a 6.8% increase in sales within its health and wellness segment, particularly in North America and Western Europe. Adjusted operating profit margin improved to 18.4%, up 110 basis points year-on-year, reflecting sustained execution of its cost optimization initiatives. The company’s organic sales growth for the full fiscal year 2025 reached 4.7%, aligning with its previously stated target range of mid-single digits. This performance was supported by a 5.1% growth in volume sales, despite persistent inflationary pressures in key markets such as India and Brazil. Unilever reported a 2.9% decline in pricing power, which it attributed to strategic price stability in essential consumer goods. Capital allocation remained focused on reinvestment, with £320 million allocated to innovation and digital transformation. Share buybacks totaled £480 million, contributing to a 4.8% reduction in share count over the year. The company maintained its dividend payout ratio at 65%, with an annual dividend of £1.38 per share. Investor sentiment remained stable in the wake of the report, with ULVR.L stock trading within a 1.2% range on the London Stock Exchange. Analysts noted that while performance was in line with expectations, long-term growth hinges on the success of Unilever’s portfolio restructuring and emerging market penetration strategies.